Legal experts are divided over how the Supreme Court will rule in an upcoming challenge to federal regulations that relaxed restrictions in 2016 and 2021 on the commonly used abortion pill mifepristone.
Advocates for mifepristone say the current system by which the drug is provided is safe, while opponents say it puts women at risk by ignoring the safety measures that used to be in place.
